Liminal BioSciences Inc. LMNL

LMNL is being very suttle but they are telling us....

[GoBBs]

....on the conf call today the CFO said this.....when Ryplazim is approved "if ever"  ... they are telling us , even in their own minds Ryplazim may not pass the FDA. There is more going on with CMC I think, I have a gut feeling they either know they cannot meet the FDA's requirements or they are they have other reasons to use these words. Think about these words "if ever" .............

[Sandpoint]

Those words  ("if ever") are consistent with the fact that no wants to partner with them. Not sure what their path forward is. Voucher??

[DryBones]

"If ever" That's the truth in 2 words for this bag lady company.  If you are a shareholder here then know this: the pumpers are working to keep you from selling your shares and putting a stop under your loses.  They are doing this for management, the Tommies and others. The Tommies will make a major divestment of this "if ever" LMNL gets an approval of anything.

[aussyspitz]

I could easily see them diluting by issuing additional warrants/shares. Since between Thomvest/Consanance they own 85% of current available shares they have the abilty to issue up to an additional 15.54 million shares/warrants and still maintain their 51% controlling interest between them. If Thomvest wants to maintain sole 51% majority without Consanace they could still dilute by issuing and

[GoBBs]

They stated on the conf call a 12 month cash runway with their current plan which includes the sale of the R&D facility in 2020.  The telling part is everytime they have a NR or a conf call they always says they expect tp resubmit in H1 ...but they NEVER say what they are actually working on , no actual update. This leads me to be very wary of them...zero trust in their words.

[sah1]

Gobbs, the company is going to close the R&D facility in Maryland not sell it. This is another clear signal that Lmnl intends to sell the Ryplazim platform probably once regulatory approvals are obtained in USA, Canada and Europe. That is, within the next 2-3 years. In this context, the question is how to maximise the selling price for the Ryplazim platform?

[GoBBs]

right Sah1 close not sell   ...CFO was mentioning cash to fund operations maybe she was referring to saving cash by closing the R%D facility. I mistakenly thought they owned the building ..I guess not.